The development of telomerase inhibitors: the G-quartet approach

Citation
Jl. Mergny et al., The development of telomerase inhibitors: the G-quartet approach, ANTI-CAN DR, 14(4), 1999, pp. 327-339
Citations number
106
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUG DESIGN
ISSN journal
02669536 → ACNP
Volume
14
Issue
4
Year of publication
1999
Pages
327 - 339
Database
ISI
SICI code
0266-9536(199908)14:4<327:TDOTIT>2.0.ZU;2-X
Abstract
Human telomeres, which consist of repeated TTAGGG sequences, have recently become the focus of intense and highly competitive biological research. Thi s scientific interest lies in their unique biological functions: telomeres are essential for genome integrity and appear to play an important role in cellular aging and cancer. As telomerase appears to be selectively expresse d in tumors versus normal cells, this enzyme represents a good target for i nhibition. Different types of telomerase inhibitors have recently been desc ribed. We will present briefly the different strategies that have been prop osed to achieve efficient telomerase inhibition, with a special emphasis on G-quartet ligands.